Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
15.01.26
/
50%
€106.22
Target price
15.01.27
€130.60
Performance (%)
-8.54%
Price
18:33
€97.38
Summary
This prediction is currently active. With a performance of -8.54%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 15.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.194% | -0.194% |
| iShares Core DAX® | -1.306% | -0.778% |
| iShares Nasdaq 100 | 1.979% | -2.045% |
| iShares Nikkei 225® | 0.593% | 6.713% |
| iShares S&P 500 | 1.425% | -0.477% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.08
01.10.25
01.10.25
€133.73
01.10.26
01.10.26
-15.41%
18:33
18:33
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-27.03%
18:33
18:33